Advertisement

Hematology and Oncology

Home Hematology and Oncology

Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits

By Ernie Mundell HealthDay Reporter THURSDAY, May 2, 2024 (HealthDay News) -- Johnson & Johnson announced Wednesday that it would pay out more than $6.5...

Healthy Lifestyle Can Overcome Genetic Predisposition to Premature Death

Optimal healthy lifestyles include never smoking, regular physical activity, adequate sleep duration, and a healthy diet

Biden Administration Could Reclassify Marijuana as Less Risky Drug

By Robin Foster HealthDay Reporter WEDNESDAY, May 1, 2024 (HealthDay News) -- The Justice Department has recommended that marijuana be reclassified as a less dangerous...

USPSTF Recommends Breast Cancer Screening for Women Aged 40 to 75 Years

Insufficient evidence seen for screening older women and for supplemental screening for women with dense breasts

Survival Gains Seen With Assignment to Experimental Group in Cancer Trials

Statistically significant survival gains observed for patients with solid tumors assigned to experimental group

Variation ID’d in Risk for Second Primary Cancer After Breast Cancer

Risk for second primary cancer after breast cancer higher for women, especially those who were younger at BC diagnosis

People With Opioid Use Disorder Less Likely to Receive Palliative Care

Difference did not persist after exclusion of people who died suddenly

Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas

Overall response rate was 25.0 percent in phase 2 study involving 17 patients

More Medical Lab Tests Will Soon Face Federal Scrutiny, FDA Says

By Ernie Mundell HealthDay Reporter MONDAY, April 29, 2024 (HealthDay News) -- Laboratory tests used by millions of Americans are soon to be classified as...

Cabozantinib Promising for Advanced Adrenocortical Carcinoma

Promising efficacy seen with a manageable safety profile in phase 2 study involving 18 patients